The three CCP-related gene signatures–HSD11B1, NDRG1 and CDCA3–may each independently predict the clinical outcomes of cutaneous melanoma patients, according to our prognostic study (both in OS and DSS). The gene discussed is CDCA3; the disease is cutaneous melanoma.